CHRNA7 and Cowden syndrome 1: Our previous studies found that Ani could indirectly activate α7 nicotinic acetylcholine receptor (α7nAChR) to decrease serum potassium through enhancement of insulin sensitivity, resulting in decline of on-site mortality in CS, and Ani might be a promising on-site remedy for CS (Fan et al., 2016).